Concepedia

Miles H. Linde

MH

Statistics

Publications

12

Citations

2K

H-Index

12

Active since

2014

Affiliations

Stanford University(Current)

Stanford Medicine

California Institute for Regenerative Medicine

Institute for Stem Cell Biology and Regenerative Medicine

BC Cancer Agency

Miles H. Linde is an author at Stanford University specializing in immunology, oncology, and medicine.

ORCID

Publications per year

2014–2024

12

Publications

12

CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors

Robbie G. Majzner, Johanna Theruvath, Anandani Nellan et al. · Clinical Cancer Research · 2019 · 672 citations · Full text

, , +15

Restoring metabolism of myeloid cells reverses cognitive decline in ageing

Paras S. Minhas, Amira Latif‐Hernandez, Melanie R. McReynolds et al. · Nature · 2021 · 521 citations · Full text

, , +14

Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication

Johanna Theruvath, Marie Ménard, Benjamin Smith et al. · Nature Medicine · 2022 · 255 citations · Full text

, , +13

Neutrophil-activating therapy for the treatment of cancer

Ian L. Linde, Tyler R. Prestwood, Jingtao Qiu et al. · Cancer Cell · 2023 · 202 citations · Full text

, , +11

Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1

Nathaniel W. Mabe, Min Huang, Guillermo Nicolás Dalton et al. · Nature Cancer · 2022 · 110 citations · Full text

, , +12

1–5 of 12